CSIMarket Company Name, Ticker, Suppliers, else..
 
Incyte Corporation  (INCY)
Other Ticker:  
 
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 


Significant EPS Decline at INCY amid the third quarter of 2022

company reported third quarter of 2022 operating profit of $138.376 millions

Published 2022-11-02T16:59:11+00:00
Goran Soko / CSIMarket.com Contributer
Revenue rise of 1.269 %, could not prevent income reduction of -39.02 % in the third quarter of 2022 financial report, in proportion to corresponding financial reporting period a year ago. Revenues were at $823.30 millions and eps at $0.50.

In comparison to the preceding financial reporting period income faded by -30.56 % from $0.72 per share and Revenue deteriorated by -9.666 % from $911.40 millions.


Net earnings of $112.775 millions in the third quarter of 2022 fell by -37.95 % from $181.739 millions in the corresponding period a year before. Incyte Corporation shifted it's focus on improving sales in the third quarter of 2022, as a result net margin eased to 13.7%.
Operating earnings, fell -41.22% to $138.376 millions, squeezing Incyte Corporation's operating margin to 16.81%, from 28.96% in the third quarter of 2021.

Incyte Corporation is expected to report next financial recent numbers on May 02, 2023.


Incyte Corporation Suppliers

Incyte Corporation rise Rates, Profitability, PE
    Recently Reported Results
Radiant Logistics Inc

Significant Income per Share Decline at the Marine Transportation company during the October to December 31 2022 time-frame

In the October to December 31 2022 Marine Transportation company declared soft top and bottom-line, where EPS dropped by -28.57 % and revenue by -16.423 % year on year. Revenue were to $278.12 millions in proportion to $332.77 millions eps at $0.10 relative to $0.14 in the similar period a preceding year.

Radiant Logistics Inc Customers

Radiant Logistics Inc Suppliers
housing-58496_960_720 Housing Starts


New housing units authorized by region

New housing units started by region
Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image4)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons Cytomx Therapeutics Inc

Underlining the financial fourth quarter of 2022 CTMX lost money at $-0.42 per share, relative to the earnings of $-0.91 per share a year before reporting season, In the prior reporting season CTMX realized $-0.35 per share.

Cytomx Therapeutics Inc Customers

Cytomx Therapeutics Inc Suppliers
Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image4)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons Acer Therapeutics Inc

For the fiscal fourth quarter of 2022 ACER increased a loss per share of $-0.54 per share compare to $-0.30 a year before and advanced loss from $-0.31 per share from the preceding quarter.

Revenues remained unscathed to $0.00 millions from $0.36 millions in the corresponding quarter a year before and sequentially Revenue Tumbled from $0.00 millions.

Acer Therapeutics Inc Suppliers

Acer Therapeutics Inc Revenue advance Rates
Pennsylvania Real Estate Investment Trust

Revenues receded by -5.307 %, at Pennsylvania Real Estate Investment Trust all along the financial span ending December 31 2022

For the fiscal fourth quarter of 2022 Pennsylvania Real Estate Investment Trust Deficit has extended of $-7.81 per share compare to $-0.43 a year before and earnings per share improved from $-14.52 per share from the prior financial reporting period.

Revenues sunk by -5.307 % to $80.65 millions from $85.17 millions in the corresponding financial reporting period a year before and sequentially Revenues advanced by 10.767 % from $72.81 millions.

Pennsylvania Real Estate Investment Trust Customers

Pennsylvania Real Estate Investment Trust advance Rates, Profitability, PE
Kitchen_stuff_By_Smoth_007_from_Christchurch_New_Zealand__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons Durable Goods Orders

Durable Goods orders rebounded in October

U.S. Durable Goods orders grew again after dipping in the last month, but orders excluding volatile transportation sector decreased. That category excludes defense and transportation and gives a better indication of longer-term trends in the private sector.
dollar-1175048_960_720 Gross Domestic Product

Gross Domestic Product grows 2.6 % in the third-quarter

U.S. economy grows to an annual rate of 2.6 %, as the U.S. trade balance improves.
factory_night_long_exposure_industry_power_industrial_energy_global-589754 Industrial production

U.S. production output continued to fell


Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image4)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons Terns Pharmaceuticals Inc

For the fiscal period ending December 31 2022 company decreased a loss per share of $-0.23 per share compare to $-0.56 a year before and earnings per share improved from $-0.44 per share from the prior quarter.

Revenues remained unaltered to $0.00 millions from $1.00 millions in the same quarter a year before and sequentially Revenues advanced from $0.00 millions.

Terns Pharmaceuticals Inc Customers

Terns Pharmaceuticals Inc Revenue growth Rates
Aerial_open_mine_by_Steve_Jurvetson__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Common Gold Royalty Corp

For the October to December 31 2022 time-frame company lost money of $-0.14 per share compare to $-0.14 a year before and from $0.00 per share from the previous quarter.

Revenues remained unaffected by 0 % to $3.94 millions from $3.94 millions in the corresponding quarter a year before and sequentially Revenues advanced from $0.00 millions.

Gold Royalty Corp Competitors, Market Share

Gold Royalty Corp Revenue elevation Rates
BuySell_pd.jpg P10 Inc

Shifting our attention to the fourth quarter of 2022 the Investment Services company profits turned positive at $0.03 per share, relative to the recent numbers of $-3.47 per share a year ago reporting period, In the preceding reporting period the P10 Inc realized $0.05 per share.

P10 Inc Customers

P10 Inc Suppliers
LLPX_2235_User.Morven__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Freightcar America Inc

Special results by the company during the financial second quarter of 2022

For the fiscal second quarter of 2022 company had turn a round to income by posting earnings per share of $0.58 per share compare to $-0.13 a year ago and earnings per share turned positive from $-1.11 per share from the preceding financial reporting period.

Revenues rose strongly by 52.021 % to $56.79 millions from $37.35 millions in the similar financial reporting period a year ago and sequentially Revenue Tumbled by -39.094 % from $93.24 millions.

Freightcar America Inc stock quotes, charts, profile

Freightcar America Inc Income Statement, Balance sheets, Cash Flow Statement
Shopping_Malll_Antwerpen_By_FaceMePLS_from_The_Hague_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Common Abercrombie And Fitch Co

Abercrombie And Fitch Co disclosed a simple Revenues growth, during the fourth quarter of 2022 earnings season

ANF disclosed declining eps on increasing revenue in the Jan 28 2023 report, where Revenue increased by 3.312 % to $1.20 billions in comparison to $1.16 billions on a year-over-year basis, while earnings per share dropped by -29.1 % to $0.78 per share, income per share was $1.10 in the similar period a year before.

Abercrombie And Fitch Co Competitors, Market Share

Abercrombie And Fitch Co advance Rates, Profitability, PE
Spectral Capital Corporation

In the financial time-frame ending December 31 2022 Spectral Capital Corporation reached break-even at $0.00 per share, opposite of $0.00 per share a year prior reporting season, In the previous reporting season FCCN realized $0.00 per share.

Spectral Capital Corporation stock quotes, charts, profile

Spectral Capital Corporation elevation Rates, Profitability, PE


Other INCY's Earnings Reports

Incyte reported third quarter 2022 earnings

Incyte reported second quarter 2022 earnings

Incyte reported first quarter 2022 earnings
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

 Stocks


Event Calendar

AMD's Profile

Stock Price

AMD's Financials

Business Description

Fundamentals

Charts & Quotes

AMD's News

Suppliers

AMD's Competitors

Customers & Markets

Economic Indicators

AMD's Growth

Company Segments

 Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness
Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

 Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

 News


At a Glance

Stocks

Economy

Industries

Other
Help


Sitemap

Advertise

About us

 Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071